ImageneBio Inc
ImageneBio Inc（IMA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IMA · 截至 2026年6月9日
活动摘要
买入笔数
7
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
ImageneBio Inc内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
IMA 季度内部人买卖趋势
IMA 内幕交易卖出 · IMA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · IMA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
IMA 高管卖出股份 · IMA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 16, 2026 | Yarema Kristin CEO · Director | Award | 85,400 | — | Form 4 |
| Dec 30, 2025 | Butler Erin PAO | Award | 22,500 | — | Form 4 |
| Dec 24, 2025 | SLATTERY JOSEPH P Director | Purchase | 16,000 | $96K | Form 4 |
| Jul 25, 2025 | Wang Stephen Hui Director | Award | 188,042 | — | Form 4 |
| Jul 25, 2025 | Wang Stephen Hui Director | Award | 50,144 | — | Form 4 |
| Jul 25, 2025 | Wang Stephen Hui Director | Award | 12,535 | — | Form 4 |
| Jul 25, 2025 | Wang Jonathan Jian Director | Award | 971,173 | — | Form 4 |
| Jul 25, 2025 | Wang Jonathan Jian Director | Award | 143,832 | — | Form 4 |
| Jul 25, 2025 | ORBIMED ADVISORS LLC Director | Award | 83,611 | $208K | Form 4 |
| Jul 25, 2025 | Bonita David P Director | Purchase | 83,611 | $2.50M⚡ | Form 4 |
| Jul 25, 2025 | Bonita David P Director | Option | 379 | — | Form 4 |
| Jul 25, 2025 | Stampacchia Otello Director | Purchase | 267,556 | $8.00M⚡ | Form 4 |
| Jul 25, 2025 | Stampacchia Otello Director | Option | 379 | — | Form 4 |
| Jul 28, 2025 | Marango Jotin CFO | Award | 15,776 | — | Form 4 |
| Jul 28, 2025 | Marango Jotin CFO | Other | 4,630 | $79K | Form 4 |
| Jul 25, 2025 | Butler Erin PAO | Award | 3,051 | — | Form 4 |
| Aug 4, 2023 | ORBIMED ADVISORS LLC Director | Award | 153,121 | — | Form 4 |
| Jun 24, 2022 | ORBIMED ADVISORS LLC Director | Purchase | 96,035 | $516K | Form 4 |
| Jun 24, 2022 | ORBIMED ADVISORS LLC Director | Purchase | 65,965 | $288K | Form 4 |
| Jun 23, 2022 | ORBIMED ADVISORS LLC Director | Purchase | 23,419 | $87K | Form 4 |
| Jun 22, 2022 | ORBIMED ADVISORS LLC Director | Purchase | 66,806 | $237K | Form 4 |
| Jun 22, 2022 | OrbiMed Genesis GP LLC Director | Purchase | 66,806 | $237K | Form 4 |
| Jun 24, 2022 | Bonita David P Director | Purchase | 96,035 | $516K | Form 4 |
| Jun 24, 2022 | Bonita David P Director | Purchase | 65,965 | $288K | Form 4 |
| Jun 22, 2022 | Bonita David P Director | Purchase | 23,419 | $87K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IMA 内幕交易
IMA 内幕交易
ImageneBio Inc（IMA）内幕交易数据来源于公司内部人（包括Wang Stephen Hui (Director), Butler Erin (PAO), Wang Jonathan Jian (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。IMA内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看ImageneBio Inc机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IMA 内幕交易 · 5个问题ImageneBio Inc（IMA）的内部人包括高管和董事，如Wang Stephen Hui (Director), Butler Erin (PAO), Wang Jonathan Jian (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026